Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
BUSINESS / Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
Japan Times
ASIA PACIFIC
Mar 22, 2022
High death rate in Hong Kong shows importance of vaccinating the elderly
The city's conflagration of cases is now killing people at a rate exceeding that of almost any country since the coronavirus emerged.
Japan Times
WORLD
Mar 19, 2022
MRNA vaccines blocked worst outcomes as variants spread, U.S. says
In recent months, when the omicron variant was dominant, three doses of an mRNA shot provided 94% protection against the worst outcomes, the CDC study said.
Japan Times
BUSINESS
Mar 17, 2022
Medicago's COVID shot rejected by WHO over company’s tobacco links
The firm's Covifenz vaccine was jointly developed by Medicago, which is owned by Mitsubishi Chemical and Philip Morris, and GlaxoSmithKline.
Japan Times
WORLD / Science & Health
Mar 17, 2022
Should Americans be worried about COVID — again?
U.S. COVID-19 trends have largely trailed those in Europe and the U.K. by a few weeks, and coronavirus cases are on the rise again in most of the Europe.
Japan Times
JAPAN
Mar 16, 2022
Japanese municipalities step up preparations for teen booster shots
About 6.8 million — or 75.3% — of people age 12 to 19 have received the initial two doses so far, according to Cabinet Secretariat data.
Japan Times
WORLD
Mar 16, 2022
U.S., EU, India and South Africa near deal on intellectual property waiver for COVID vaccines
The tentative agreement does not include COVID-19 treatments or tests, and also has limitations likely to exclude China from any waiver, according to one source.
Japan Times
WORLD / Science & Health
Mar 16, 2022
Pfizer asks U.S. regulator to clear another booster for older adults
The drugmaker and its partner BioNTech have submitted data to the FDA from Israel, which began offering a fourth shot to older people and health care workers last year.
Japan Times
JAPAN / FOCUS
Mar 15, 2022
Japanese firms near domestic rollout of their COVID-19 vaccines
Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.
Japan Times
WORLD
Mar 12, 2022
WHO exploring when and how to declare end of COVID emergency
Such a declaration would be not just a meaningful symbolic step, and would add momentum to the rollback of many pandemic-era public health policies.
Japan Times
WORLD / Science & Health
Mar 11, 2022
New COVID vaccine findings pose tough questions for parents of young children
For adults, vaccines proved to be safe and powerfully protective in clinical trials and were speedily authorized for use. But the trials in children were complicated by the arrival of virus variants.
Japan Times
JAPAN
Mar 11, 2022
Israel, Sweden and Chile are recommending a fourth COVID-19 jab. What about Japan?
If fourth doses in Japan are administered six months after third shots, a second booster rollout could begin as early as this summer.
Japan Times
JAPAN
Mar 6, 2022
Shionogi says its COVID-19 shot is effective and safe
The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.
Japan Times
BUSINESS / Companies
Feb 25, 2022
Japan’s petrochemical firms need to merge to survive, Mitsubishi Chemical CEO says
Jean-Marc Gilson compared the situation facing the chemical industry to other industries Japan once dominated, such as semiconductors and flat-screen televisions.
Japan Times
ASIA PACIFIC
Feb 25, 2022
China steps in to steer Hong Kong's COVID-19 crisis as risks loom
Hong Kong has stepped up anti-coronavirus measures, including plans for mass testing buttressed by equipment, testing vehicles and personnel from the mainland.
Japan Times
JAPAN
Feb 24, 2022
Japan to accept Johnson & Johnson COVID vaccine for border entry next month
The J&J shot, which has not been approved in Japan, will join a list of three other shots that have been approved by regulators as sufficient for nonresidents to enter.
Japan Times
ASIA PACIFIC
Feb 24, 2022
Virus-hit Hong Kong invokes emergency powers to allow in China medics
On Wednesday, Hong Kong reported a record 8,674 new COVID-19 infections as the global financial hub prepares for compulsory testing of its 7.4 million people.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?